06.10.09
Velesco Pharmaceutical Services opened a manufacturing facility and office in Kalamazoo, MI and has moved its Ann Arbor, MI labs to the Michigan Life Science and Innovation Center (MLSIC) in Plymouth, MI.
The company's new 10,000-sq.-ft. office and manufacturing facility in Kalamazoo will manufacture non-sterile cGMP clinical trial supplies for pharma companies and will focus on providing clinical supplies for early phase trials. Product offerings include powder-in-capsule, powder-in-bottle, ointments/creams, oral and topical liquids, over-encapsulation for blinded studies and packaging.
"Velesco's addition of clinical trial material manufacturing capabilities allows us to provide a full service offering to our clients as they move from pre-clinical drug development into the clinic," said Velesco chief executive officer and co-founder David Barnes, Ph.D.
"The life science talent in Michigan compelled us to stay and grow here," said Velesco chief operating officer and co-founder Gerry Cox. "There's a uniquely high concentration of the experienced pharmaceutical researchers Velesco needs to be successful in its aggressive growth plans."
The company's new 10,000-sq.-ft. office and manufacturing facility in Kalamazoo will manufacture non-sterile cGMP clinical trial supplies for pharma companies and will focus on providing clinical supplies for early phase trials. Product offerings include powder-in-capsule, powder-in-bottle, ointments/creams, oral and topical liquids, over-encapsulation for blinded studies and packaging.
"Velesco's addition of clinical trial material manufacturing capabilities allows us to provide a full service offering to our clients as they move from pre-clinical drug development into the clinic," said Velesco chief executive officer and co-founder David Barnes, Ph.D.
"The life science talent in Michigan compelled us to stay and grow here," said Velesco chief operating officer and co-founder Gerry Cox. "There's a uniquely high concentration of the experienced pharmaceutical researchers Velesco needs to be successful in its aggressive growth plans."
